Abeona Therapeutics ABEO
NASDAQ ABEO
$4.40 -0.07 (-1.57%)
At close: Oct 23, 2026 · 4:00 PM EDT

Abeona Therapeutics (ABEO) EV to CFO (2013 - 2014)

Updated

Abeona Therapeutics' EV to CFO was 80375.59 in Q1 2014, down 99.0% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) EV to CFO (2013 - 2014) Analysis & Trends

On a trailing twelve-month basis, Abeona Therapeutics' EV to CFO was 80361.53 through Mar 31, 2014; for FY2013, it was 8040026.94.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Abeona Therapeutics 251.79 Mn -462.16 Mn 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 80,375.59
Dec 31, 2013 8.04 Mn
API Access

Abeona Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ABEO&period=max&api_key=YOUR_API_KEY